Stockreport

Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update

Selecta Biosciences, Inc.  (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
PDF 3-month Phase 2 data presented at PANLAR 2018 indicate SEL-212 (SVP-Rapamycin + pegsiticase) product profile may provide better and more sustained serum uric acid contro [Read more]